These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2962803)

  • 1. Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro.
    Hughes A; Thom S; Goldberg P; Martin G; Sever P
    Clin Sci (Lond); 1988 Feb; 74(2):207-11. PubMed ID: 2962803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide.
    van der Zander K; Houben AJ; Kroon AA; de Leeuw PW
    Cardiovasc Res; 1999 Dec; 44(3):595-600. PubMed ID: 10690292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of local angiotensin converting enzyme inhibition on the action of atrial natriuretic peptide in the human forearm.
    Cockcroft JR; Allen MJ; Benjamin N; Webb DJ
    J Hum Hypertens; 1989 Feb; 3(1):49-52. PubMed ID: 2542549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial and venous effects of atrial natriuretic peptide in the human forearm.
    Doorenbos CJ; Blauw GJ; van Brummelen P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):333-40. PubMed ID: 1829369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Hiramori K
    Circulation; 1994 Sep; 90(3):1210-4. PubMed ID: 8087930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular responses to local atrial natriuretic peptide infusion in man.
    Webb DJ; Benjamin N; Allen MJ; Brown J; O'Flynn M; Cockcroft JR
    Br J Clin Pharmacol; 1988 Sep; 26(3):245-51. PubMed ID: 2972307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure.
    Hirooka Y; Takeshita A; Imaizumi T; Suzuki S; Yoshida M; Ando S; Nakamura M
    Circulation; 1990 Jul; 82(1):147-53. PubMed ID: 2163779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
    Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vasodilator potency of atrial natriuretic peptide in man.
    Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Ritz R; Bühler FR
    Circulation; 1987 Jan; 75(1):221-8. PubMed ID: 2947742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide increases human capillary filtration and venous distensibility.
    Ando S; Imaizumi T; Harada S; Hirooka Y; Takeshita A
    J Hypertens; 1992 May; 10(5):451-7. PubMed ID: 1317906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for a direct vasodilatory effect of celiprolol on human vasculature in vivo or in vitro.
    Hughes A; Martin G; Goldberg P; Thom S; Sever P
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):589-92. PubMed ID: 2447410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensives.
    Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Bühler FR
    J Hypertens Suppl; 1987 Dec; 5(5):S55-8. PubMed ID: 2965230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide.
    Ando K; Ito Y; Ogata E; Fujita T
    Am Heart J; 1992 Jan; 123(1):111-6. PubMed ID: 1530893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
    Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.
    Hughes A; Thom S; Martin G; Redman D; Hasan S; Sever P
    Br J Clin Pharmacol; 1986 Nov; 22(5):535-40. PubMed ID: 2878679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
    Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide alters vasodilation to atrial natriuretic peptide via nitric oxide and endothelin-1: time-dependent effects.
    Scicluna JK; Mansart A; Ross JJ; Reilly CS; Brown NJ; Brookes ZL
    Eur J Pharmacol; 2009 Oct; 621(1-3):67-70. PubMed ID: 19737554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor.
    Hammerer-Lercher A; Fersterer J; Holzmann S; Bonatti J; Ruttmann E; Hoefer D; Mair J; Puschendorf B
    Clin Sci (Lond); 2006 Sep; 111(3):225-31. PubMed ID: 16709152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
    Müller FB; Erne P; Raine AE; Bolli P; Linder L; Resink TJ; Cottier C; Bühler FR
    J Hypertens Suppl; 1986 Jun; 4(2):S109-14. PubMed ID: 2941531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.